Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Wai, Bryan ^a,b   Kearney, Leighton G ^a,b   Hare, David L ^a,b   Ord, Michelle ^a   Burrell, Louise M ^a,b   Srivastava, Piyush M ^a,b  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Beta blockers; Diabetes; Glycaemic control; Systolic heart failure

Indexed keywords

BISOPROLOL; CARVEDILOL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CARBAZOLE DERIVATIVE; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DRUG DOSE TITRATION; DRUG EFFECT; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SYSTOLIC HEART FAILURE; TREATMENT DURATION; ALBUMINURIA; AUSTRALIA; BLOOD; DIABETIC NEPHROPATHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TEACHING HOSPITAL; TIME; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; BISOPROLOL; CARBAZOLES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE, SYSTOLIC; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, TEACHING; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; PROPANOLAMINES; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VICTORIA;

EID: 84857022970     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-14     Document Type: Article

References (24)

1. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001, 344:1651-1658. 10.1056/NEJM200105313442201, 11386263.
2. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46:e1-82. 10.1016/j.jacc.2005.08.022, 16168273.
3. Yilmaz MB, Refiker M, Guray Y, Guray U, Altay H, Demirkan B, Caldir V, Korkmaz S. Prescription patterns in patients with systolic heart failure at hospital discharge: why beta blockers are underprescribed or prescribed at low dose in real life?. Int J Clin Pract 2007, 61:225-230. 10.1111/j.1742-1241.2006.01157.x, 17263710.
4. ASHP therapeutic position statement on the use of beta-blockers in survivors of acute myocardial infarction. Am J Health Syst Pharm 2002, 59:2226-2232.
5. MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R, Aguilar D, Krum H, McMurray JJ. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 2008, 29:1224-1240.
6. Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, Leyva F, Proudler AJ, Coats AJ, Anker SD. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005, 46:1019-1026. 10.1016/j.jacc.2005.02.093, 16168285.
7. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001, 103:2668-2673.
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj 2000, 321:405-412. 10.1136/bmj.321.7258.405, 27454, 10938048.
9. Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P, Wright JT, Oakes R, Lukas MA, et al. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. Jama 2004, 292:2227-2236. 10.1001/jama.292.18.2227, 15536109.
10. Srivastava PM, Thomas MC, Calafiore P, MacIsaac RJ, Jerums G, Burrell LM. Diastolic dysfunction is associated with anaemia in patients with Type II diabetes. Clin Sci (Lond) 2006, 110:109-116.
11. Fonseca V, Bakris GL, Bell DS, McGill JB, Raskin P, Messerli FH, Phillips RA, Katholi RE, Wright JT, Waterhouse B, et al. Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI. Diabet Med 2007, 24:759-763. 10.1111/j.1464-5491.2007.02151.x, 17451422.
12. Kveiborg B, Hermann TS, Major-Pedersen A, Christiansen B, Rask-Madsen C, Raunso J, Kober L, Torp-Pedersen C, Dominguez H. Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study. Cardiovasc Diabetol 2010, 9:21. 10.1186/1475-2840-9-21, 2893119, 20500877.
13. Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ, Dietze GJ. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens 1996, 14:489-494.
14. Bakris GL, Fonseca V, Katholi RE, McGill JB, Messerli F, Phillips RA, Raskin P, Wright JT, Waterhouse B, Lukas MA, et al. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes. Hypertension 2005, 46:1309-1315. 10.1161/01.HYP.0000190585.54734.48, 16286578.
15. Arnold JM, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, Lonn E, Pogue J, Bosch J. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2003, 107:1284-1290. 10.1161/01.CIR.0000054165.93055.42, 12628949.
16. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KM, Herman WH, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002, 39:445-459. 10.1053/ajkd.2002.31388, 11877563.
17. de Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?. Nephrol Dial Transplant 2003, 18:10-13. 10.1093/ndt/18.1.10, 12480951.
18. Kirpichnikov D, McFarlane SI, Sowers JR. Heart failure in diabetic patients: utility of beta-blockade. J Card Fail 2003, 9:333-344. 10.1054/jcaf.2003.36, 13680555.
19. Jawa A, Nachimuthu S, Pendergrass M, Asnani S, Fonseca V. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension. J Diabetes Complications 2008, 22:303-308. 10.1016/j.jdiacomp.2007.05.003, 2590589, 18413195.
20. Falskov B, Hermann TS, Raunso J, Christiansen B, Rask-Madsen C, Major-Pedersen A, Kober L, Torp-Pedersen C, Dominguez H. Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study. Cardiovasc Diabetol 2011, 10:91. 10.1186/1475-2840-10-91, 3212926, 21999413.
21. Pollare T, Lithell H, Selinus I, Berne C. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Bmj 1989, 298:1152-1157. 10.1136/bmj.298.6681.1152, 1836369, 2500169.
22. Bell DS, Bakris GL, McGill JB. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients. Diabetes Obes Metab 2009, 11:234-238. 10.1111/j.1463-1326.2008.00927.x, 18564334.
23. Haas SJ, Vos T, Gilbert RE, Krum H. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 2003, 146:848-853. 10.1016/S0002-8703(03)00403-4, 14597934.
24. Konishi M, Haraguchi G, Kimura S, Inagaki H, Kawabata M, Hachiya H, Hirao K, Isobe M. Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure. Circ J 2010, 74:1127-1134. 10.1253/circj.CJ-09-0989, 20354334.